BackCancer Genetics Overview

Cancer Genetics Goodwill

Cancer Genetics's goodwill is $3M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$2.98M

Peer trimmed avg / median

Loading

Cancer Genetics Goodwill History

Loading

Cancer Genetics vs. peers: Goodwill Comparison

Loading

Cancer Genetics Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cancer Genetics (CGIX) FAQ

As of the most recent data (December 2020), CGIX shows a goodwill of $3M. Scroll down for historical charts and peer comparison views.

Tracking CGIX's goodwill over time shows whether Cancer Genetics is scaling, shrinking, or reshaping that part of the business. The current reading is $3M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Cancer Genetics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $3M) with ownership activity and broader fundamentals.

Cancer Genetics's goodwill is $3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.